tradingkey.logo
tradingkey.logo
Search

Mira Pharmaceuticals Inc

MIRA
Add to Watchlist
0.780USD
+0.030+4.01%
Close 08-14 16:00ETQuotes delayed by 15 min
32.79MMarket Cap
LossP/E TTM

Forecast

Currency: USD Updated: 2026-08-14
Previous score
0.00
Change
0
No earnings forecast score is currently available for Mira Pharmaceuticals Inc. The Biotechnology & Medical Research industry's average is 8.10. The average price target is 3.00, with a high of 3.00 and a low of 3.00.

Analyst Rating

Based on 0 analysts
--
Current Rating
3.000
Target Price
+109.79%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Mira Pharmaceuticals Inc
MIRA
0
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Mira Pharmaceuticals Inc's price target?

Analysts forecast that Mira Pharmaceuticals Inc's price target is USD 3.00, with the highest forecast at USD 3.00 and the lowest forecast at USD 3.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.